RSS   Newsletter   Contact   Advertise with us

Minerva Neurosciences appoints two to board

Staff Writer | Waltham, Mass., USA | December 12, 2017
Minerva NeurosciencesDecember 12, 2017, Waltham, Mass., USA - Minerva Neurosciences, a biopharmaceutical company, announced the election of William F. Doyle and Hans Peter Hasler to the board of directors of the company.
William F. Doyle is Executive Chairman of Novocure Ltd. (NVCR), a commercial stage oncology company pioneering a novel therapy for solid tumors, where he has served as Chairman of the Board since 2009 and a director since 2004.

Mr. Doyle has also been the Managing Director of WFD Ventures LLC, a private venture capital firm he co-founded, since 2002.

Previously, Mr. Doyle was a member of Johnson & Johnson’s Medical Devices and Diagnostics Group Operating Committee and Vice President, Licensing and Acquisitions.

While at Johnson & Johnson, he was also Chairman of the Medical Devices Research and Development Council, Worldwide President of Biosense-Webster, Inc. and a member of the boards of Cordis Corporation and Johnson & Johnson Development Corporation, Johnson & Johnson’s venture capital subsidiary.

Earlier in his career, Mr. Doyle was a management consultant in the global healthcare practice of McKinsey & Company.

His additional board positions include the private company, Blink Health Ltd., and OptiNose US, Inc. (OPTN).

Mr. Doyle holds an S.B. in materials science and engineering from the Massachusetts Institute of Technology and an M.B.A. from Harvard Business School.

Hans Peter Hasler is Founder and Chief Executive Officer of Vicarius Pharma AG, a privately held company that provides strategic options to non-European bio-pharma companies in bringing late-stage assets to the European market.

He also is a Senior Advisor at SBTech Global Advisory.

Mr. Hasler's prior corporate experience includes Elan Corporation, where he was Chief Operating Officer, and Biogen, Inc., where his positions included Chief Operating Officer, Executive Vice President, Head of Global Neurology and International.

Previously, Mr. Hasler was at Wyeth Pharmaceuticals as Senior Vice President, Chief Marketing Officer and Managing Director of Wyeth Group Germany and General Manager, Wyeth-Lederle Switzerland, Austria and ECE.

Mr. Hasler is Chairman of the Board of HBM Healthcare Investments AG in Zug, Switzerland and Director of the Board of Dr. Reddy’s Laboratories in Hyderabad, India.

He holds a Federal Swiss Commercial Diploma and a Marketing Manager Certificate from the Swiss Institute of Business Economy SIB, Zurich, Switzerland.


 LATEST MOVES FROM Massachusetts 


MORE INSIDE POST